Close Menu

NEW YORK – NeuMoDx has filed a response with the District of Delaware courts defending itself against claims levied by Becton Dickinson that the molecular diagnostics developer infringed on certain patents.

In court documents filed in Delaware on Friday, the Ann Arbor-based maker of high-throughput and mid-throughput PCR-based molecular diagnostic instruments and assays denied that it infringes any claim of the asserted patents and said that the asserted patents are invalid.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.